This case report suggests a possible association between venlafaxine use and acute myocardial ischemia in patients with pre-existing ischemic heart disease.
Answers are grounded in this paper and cite their sources.
May warrant caution with venlafaxine in IHD patients; hypothesis-generating case report leaves causal link open.
Venlafaxine, a structurally novel antidepressant, belongs to a new generation of antidepressants--the serotonin/noradrenaline reuptake inhibitors. In clinical trials, venlafaxine was found safe and effective in most patients. However, significant changes in vital signs (hyper- and hypotension) and cardiac conduction abnormalities were observed in a few patients, notably in elderly patients. We present a case of an elderly woman with a pre-existing history of ischaemic heart disease, who was treated with venlafaxine, and developed acute myocardial ischaemia within the first week of treatment. This is the first report of a possible association between an acute cardiovascular event and venlafaxine. The association of venlafaxine treatment with ischaemic events could be explained by its unique pharmacological and haemodynamic properties.
No takes yet. Share an insight, caveat, or question.
Reznik et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: